Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Toxicologic Pathology
|
February 21, 2013
The rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals
Prashant R Nambiar, Daniel Morton
Toxicologic Pathology
|
April 24, 2015
Regulatory Forum Commentary* Counterpoint: Dose Selection for rasH2 Mouse Carcinogenicity Studies
Prashant R Nambiar, Daniel Morton
Regulatory Toxicology and Pharmacology : RTP
|
October 24, 2012
Human safety risk assessment of lymph node angiomas observed in 2-year carcinogenicity studies in rats
Zaher A Radi, Daniel Morton
Toxicologic Pathology
|
June 14, 2011
Re: analysis of pharmaceutical experience with decades of rat carcinogenicity testing. Introduction to article by Sistare et al
Daniel Morton, Carl L Alden
Toxicologic Pathology
|
October 17, 2013
The colon: from banal to brilliant
Rani S Sellers, Daniel Morton
ACS Central Science
|
October 6, 2017
Collective Approach to Advancing C-H Functionalization
Huw M L Davies, Daniel Morton
Organic & Biomolecular Chemistry
|
August 19, 2007
Photochemical transformations of pyridinium salts: mechanistic studies and applications in synthesis
Teresa Damiano, Daniel Morton, Adam Nelson
Chemical Society Reviews
|
March 2, 2011
Guiding principles for site selective and stereoselective intermolecular C-H functionalization by donor/acceptor rhodium carbenes
Huw M L Davies, Daniel Morton
Angewandte Chemie (International Ed. in English)
|
September 13, 2014
C-H functionalization: collaborative methods to redefine chemical logic
Huw M L Davies, Daniel Morton
The Journal of Organic Chemistry
|
January 16, 2016
Recent Advances in C-H Functionalization
Huw M L Davies, Daniel Morton
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Toxicologic Pathology
|
February 21, 2013
The rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals
Prashant R Nambiar, Daniel Morton
Toxicologic Pathology
|
April 24, 2015
Regulatory Forum Commentary* Counterpoint: Dose Selection for rasH2 Mouse Carcinogenicity Studies
Prashant R Nambiar, Daniel Morton
Regulatory Toxicology and Pharmacology : RTP
|
October 24, 2012
Human safety risk assessment of lymph node angiomas observed in 2-year carcinogenicity studies in rats
Zaher A Radi, Daniel Morton
Toxicologic Pathology
|
June 14, 2011
Re: analysis of pharmaceutical experience with decades of rat carcinogenicity testing. Introduction to article by Sistare et al
Daniel Morton, Carl L Alden
Toxicologic Pathology
|
October 17, 2013
The colon: from banal to brilliant
Rani S Sellers, Daniel Morton
ACS Central Science
|
October 6, 2017
Collective Approach to Advancing C-H Functionalization
Huw M L Davies, Daniel Morton
Organic & Biomolecular Chemistry
|
August 19, 2007
Photochemical transformations of pyridinium salts: mechanistic studies and applications in synthesis
Teresa Damiano, Daniel Morton, Adam Nelson
Chemical Society Reviews
|
March 2, 2011
Guiding principles for site selective and stereoselective intermolecular C-H functionalization by donor/acceptor rhodium carbenes
Huw M L Davies, Daniel Morton
Angewandte Chemie (International Ed. in English)
|
September 13, 2014
C-H functionalization: collaborative methods to redefine chemical logic
Huw M L Davies, Daniel Morton
The Journal of Organic Chemistry
|
January 16, 2016
Recent Advances in C-H Functionalization
Huw M L Davies, Daniel Morton
Page
of 8